Quick Answer
Scinai Immunotherapeutics Ltd. reported Common Stock Shares Outstanding of 3.41 billion shares for the year ending 2024.
- Scinai Immunotherapeutics Ltd. showed an increase of +83.7% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from Scinai Immunotherapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 7, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Scinai Immunotherapeutics Ltd.'s Common Stock Shares Outstanding has grown by 361.7%.
- Historical annual values: Fiscal year 2024: 3.41 billion shares | Fiscal year 2023: 1.86 billion shares | Fiscal year 2022: 989.29 million shares | Fiscal year 2021: 739.05 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: